BARD buy safety needle
The IV device market continues to consolidate as BARD pay $68 million for Specialized Health Products International Inc… the company primarily make safety needles for the intravenous chemotherapy market.
“The deal represents a good fit, in our view, and should be neutral to earnings in 2008,” said Lehman Brothers analyst Bob Hopkins, in a note to investors.Click here for the full story.
Other stories
Loading…











